Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders

NCT03622749 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03622749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03622749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2019
Completion date
January 1, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, transcranial magnetic stimulation